In addition, this case shows that propranolol can be administered safely and has a significant therapeutic effect on Gorham syndrome by reducing circulating VEGF-A rather than by changing VEGF-C or Fms-like tyrosine kinase-1 (FLT-1) levels. This evidence concerns the gene VEGFC and Gorham-Stout disease.